Seres Therapeutics, Inc. Warrants Not Settleable in Cash, Fair Value Disclosure
Seres Therapeutics, Inc. (MCRB) had Warrants Not Settleable in Cash, Fair Value Disclosure of $0 as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2017-03-16
- 2016-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $0.00.
- 2016-09-30: Warrants Not Settleable in Cash, Fair Value Disclosure $0.00.
- 2016-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $0.00.
- 2016-03-31: Warrants Not Settleable in Cash, Fair Value Disclosure $0.00.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2015-09-30 | $17.26K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $17.26K 10-Q · filed 2015-08-10 |
| 2014-12-31 | $1.58M 10-K · filed 2017-03-16 |
| 2014-09-30 | $7.82K 10-Q · filed 2015-11-12 |
| 2014-06-30 | $1.59K 10-Q · filed 2015-08-10 |
| 2013-12-31 | $164.00K 10-K · filed 2017-03-16 |
| 2012-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |